A KRAS-Associated Signature for Prognostic, Immune and Chemical Anti-Cancer Drug-Response Prediction in Colon Cancer

• Main Authors: Kangjia Luo (Author), Yanni Song (Author), Zilong Guan (Author), Suwen Ou (Author), Jinhua Ye (Author), Songlin Ran (Author), Hufei Wang (Author), Yangbao Tao (Author), Zijian Gong (Author), Tianyi Ma (Author), Yinghu Jin (Author), Rui Huang (Author), Feng Gao (Author), Shan Yu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: KRAS mutation, one of the most important biological processes in colorectal cancer, leads to poor prognosis in patients. Although studies on KRAS have concentrated for a long time, there are currently no ideal drugs against KRAS mutations.Methods: Different expression analysis and weight...